Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COPD; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), in May2024 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Primary immunization series complete), for COVID-19 immunization. The following information was reported: CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "unknown", described as "COPD". Additional information: During an inbound call with general vaccine questions, the patient stated, "I'm curious about getting a COVID vaccine. Initially, when they first came out, I took nothing but Pfizer, and now-the last time I've had a vaccine was May of 2024....I have COPD, so I'm sort of in a position to really want to make sure I've got myself covered with booster protection." The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.